• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China AI medical device market whitepaper released

China AI medical device market whitepaper released

China AI medical device market
Friday, 28 April 2023 / Published in Medical Device, News, NMPA Registration in China

China AI medical device market whitepaper released

China AI medical device market is still in its early stages. Only 47 AI medical devices have been approved for listing in China so far, but this is set to grow. The intersection of artificial intelligence (AI) and the medical device industry is becoming a new growth driver for the sector, according to a whitepaper released by the Intelligent Medical Device Industry Development Research Working Group.

On April 7, 2023, the Center for Medical Device Evaluation (CMDE) released an article to share an overview of the latest developments of the AI medical device industry in China, and also referred to the whitepaper issued by the Intelligent Medical Device Industry Development Research Working Group. According to the article, the medical device industry is a crucial area for building strong manufacturing capabilities and China’s medical device sector has grown rapidly in recent years. By the end of 2020, China’s medical device industry had generated over CNY 103.92bn in revenue, with a five-year compound annual growth rate of 10.5%. However, to continue this growth, high-end medical devices require the integration of AI, big data, and cloud computing to enable intelligent digital transformation, upgrade product performance and create leapfrog development opportunities.

AI medical devices are empowering the medical industry by improving the supply capacity of medical equipment, optimising treatment processes, and innovating medical methods. The use of AI technology is transforming diagnostic imaging equipment by enabling scanning and image reconstruction, which is essential for assisting doctors in accurate diagnoses. AI medical devices are also standardising clinical treatment practices and reducing medical errors, resulting in improved medical quality. The combination of AI medical devices and wireless communication technologies such as 5G is enabling remote collaboration between doctors, medical devices and patients, and advancing the detection time of some diseases.

The artificial intelligence medical device industry has high application value and wide coverage, attracting participation from enterprises and units across multiple fields. The industry ecosystem includes partners in areas such as standard specification, support environment, infrastructure, intelligent hub and intelligent application. To date, 47 AI medical devices have been approved for listing in China, covering cardiovascular, brain, eye, lung, orthopaedic, oncology and other disease areas, with expected uses including assisted triage and assessment, quantitative calculation, lesion detection, and target area outlining.

However, the development of the AI medical device industry is still in the early stages and a commercial closed loop has yet to be formed, with large-scale procurement based on clinical value yet to begin. While there have been breakthroughs at the registration access level, price access and health insurance access are still at an early stage. At the price access level, AI medical devices have not yet been included in the National Medical Service Price Item Specification, and only Shanghai, Guangdong and Shandong provinces and cities have included AI technology descriptions in their provincial medical service item filing lists.

Further Information

Read the full CMDE article on AI medical devices industry development in China.

Discover our services for medical device registration, renewals and NMPA Legal Agent.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

Webinar: MedTech pathway to China: Market opportunities and regulatory hurdles
Webinar: MedTech pathway to China: Market opportunities and regulatory hurdles
drug-device
Cisema experts cited in drug-device combination news
NMPA Major Updates Concerning IVDs

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...
  • webinar_medical-device-market-authorisation

    Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

    Cisema is delighted to hold a Masterclass with ...
  • generative AI services

    China’s generative AI interim measures now in effect

    China’s generative AI interim measures fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP